Newborn Screening Laboratory definition

Newborn Screening Laboratory means a laboratory operated by the Department or a laboratory certified by the Department to conduct the tests and carry out the follow-up required by these procedures.
Sample 1Sample 2Sample 3
Newborn Screening Laboratory means an entity contracted with the Department under A.R.S. § 36-694(C) to per- form the newborn screening test.
Sample 1Sample 2
Newborn Screening Laboratory means a laboratory with which the Department contracts to conduct testing of the newborn screening specimens.
Sample 1

Examples of Newborn Screening Laboratory in a sentence

  • Newborn Screening Laboratory results have important implications for all children born in the State of Michigan.

  • It is then sent to the National Newborn Screening Laboratory in Queen Elizabeth University Hospital for analysis.

  • The function of the Newborn Screening Laboratory is to ensure the health and well-being of all infants born in the State of Michigan as mandated by Michigan law and accepted medical practice.

  • Confirmation of the appointment (and diagnosis, when available) should be sent to the Scottish Newborn Screening Laboratory.

  • Authorized providers can access newborn screening results on-line through the State Electronic Notification Surveillance System (SendSS) or DPH Newborn Screening Laboratory web portal (eReports): https://services.georgia.gov/dph/eReports/.

  • Although it is widely available not all personnel involved in the programme have a copy of these Guidelines from the National Newborn Screening Laboratory (NNSL).

  • The demographic information collected at the time of pulse oximetry screening will be used to match the infant’s CCHD screening results to the blood spot card sent to theMDHHS Newborn Screening Laboratory.

  • To standardise the process of newborn screening testing the National Newborn Screening Laboratory (NNSL) developed APractical Guide to Newborn Screening in Ireland (2001)3 The majority of hospitals follow these guidelines.

  • The position of laboratory scientist has changed since the position was last reviewed due to the rapid technological development in the Newborn Screening field we anticipate a continued increase of new disease conditions to be added to the Federal recommendation list (ACMG-American College of Medical Genetic) and need experienced staff to help develop new technologies and modify current technologies used in the Newborn Screening Laboratory.

  • The Colorado Newborn Screening Laboratory complies with the Clinical Laboratory Improvement Amendments of 1988 (CLIA).


More Definitions of Newborn Screening Laboratory

Newborn Screening Laboratory means a laboratory operated by the
Sample 1

Related to Newborn Screening Laboratory

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Health screening means the use of one or more diagnostic tools to test a person for the presence or precursors of a particular disease.

  • Approved laboratory means a laboratory that is listed in the national conference of interstate milk shipments list of sanitation compliance and enforcement ratings distributed by the United States food and drug administration and as approved by the director.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Dental laboratory means a person, firm or corporation

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Screening Test Technician (STT) means anyone who instructs and assists individuals in the alcohol testing process and operates an ASD.

  • Laboratory or “LANL” means the geographical location of Los Alamos National Laboratory, a federally funded research and development center owned by the DOE / NNSA.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Certified laboratory means a laboratory that is on an approved list issued by us.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Non-Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • Alcohol Screening Device (ASD) means a breath or saliva device, other than an Evidential Breath Testing Device (EBT), that is approved by the National Highway Traffic Safety Administration and placed on its Conforming Products List for such devices.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Healing arts screening means the testing of human beings using x-ray machines for the detection or evaluation of health indications when such tests are not specifically and individually ordered by a licensed practitioner of the healing arts legally authorized to prescribe such x-ray tests for the purpose of diagnosis or treatment.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.